OCTOBER 2023LIFE SCIENCES REVIEW4IN MY OPINION08Piero Rijli, Corporate Director, Regulatory Activities and Market Access, MENARINI GroupThe value of new antibiotics in the fight against AMR12COVER STORYFEATURED CompaniesClifton InsightDr. Howard Thom,Senior DirectorInSpired Health OutcomesDavid Churchman,Founder & Managing Director3330CONTENTSHEOR SOLUTIONS PROVIDERS IN UK - 2023TOP 5HOW CAN WE TACKLE THE HEALTH EQUITY GAP TO INNOVATIVE MEDICINES?Silvy Mardiguian,Market Access Director, UK & Ireland, BeiGene [SHA: 688235]
< Page 3 | Page 5 >